Brandt Jewell joins Mark to discuss private equity (PE) deals for healthcare entities and the operational considerations PE firms and medical groups alike should consider during the transaction. Brandt and Mark identify opportunities to discuss during due diligence, medical group optimization opportunities after the deal is complete, and the critical characteristics of attractive provider groups.

Contact Information

Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, or your preferred podcast provider. Like what you hear? Leave a review! Not there? Let us know!

We welcome all feedback from our listeners. Please submit questions on any of the topics we discuss or about issues that interest you. You can also recommend topics for future episodes. 

• Email us: [email protected]
• Connect with us on LinkedIn: Coker Group Company Page
• Follow us on Twitter: @cokergroup
• Follow us on Instagram: @cokergroup

 

Episode Synopsis

Brandt and Mark review how to identify opportunities during the due diligence phase of the transaction. The specialty or specialty mix of a medical group is a key decision factor when considering a PE deal because a financial return is the primary objective of that type of deal. They also discuss developing a consistent and scalable infrastructure, the pitfalls of aggregating physician operations, and continuing status quo operations after the agreement.

PE Deal Extras

Blog: Post-Merger Integration Strategy Starts Early

Blog: The Role of Management Services in Private Equity Transactions

Blog: Defining Private Equity Transactions in Healthcare and Understanding Deal Options for Medical Groups

Blog: Strategic Variables in Private Equity Transactions

Podcast: Episode 51: Forming a Management Services Organization

Podcast: Episode 34: Private Equity: The Next Stage in Physician Practice Transactions

Article: The Private Equity Model for Medical Group Transactions